UBS/CALL/GALENICA/75.002/0.05/20.12.24 | Market Closed - Swiss Exchange 16:20:00 06/06/2024 BST | ||
| 0.2 CHF | +5.26% |
|
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
GALENICA AG
Latest news about GALENICA AG
| Date | Price | Change |
|---|---|---|
| 06/06/24 | 0.2 | +5.26% |
| 03/06/24 | 0.19 | -5.00% |
| 31/05/24 | 0.2 | +17.65% |
| 30/05/24 | 0.17 | +6.25% |
| 29/05/24 | 0.16 | -5.88% |
Delayed Quote Swiss Exchange
Last update June 06, 2024 at 04:20 pm
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | GALENICA AG |
| Issuer | UBS |
| HGALMU | |
| ISIN | CH1327270273 |
| Date issued | 04/03/2024 |
| Strike | 75 CHF |
| Maturity | 20/12/2024 (197 Days) |
| Parity | 20 : 1 |
| Emission price | 0.23 CHF |
| Emission volume | N/A |
| Settlement | physical |
| Currency | CHF |
Technical Indicators
| Highest since issue | 0.22 CHF |
|---|---|
| Lowest since issue | 0.12 CHF |
| Spread | 0.01 CHF |
| Spread % | 4.76% |
Company Profile
Galenica AG, previously Galenica Sante Ltd, is a Switzerland-based healthcare services and products provider. The Company's business i divided into three business sectors: Retail, Products & Brands, and Services. The Company manages a locally established pharmacies network in Switzerland. It develops and distributes its own product portfolio, as well as cooperates with a range of business partners, such as Pierre Fabre, Ales Groupe and Vitor Consumer Health for marketing and distribution of such brands as Perskindol, Triofan, A-Derma, Lierac, Phyto, Anti-Brumm and Algifor. Galenica Sante's Services business sector is responsible for management of such logistics sector companies as Galexis, Unione Farmaceutica Distribuzione, Alloga and Medifilm.
Sector
-
Consensus: Galenica AG
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
74.1
CHF
Average target price
77
CHF
Spread / Average Target
+3.91%
- Stock Market
- Warrants
- HGALMU Warrant
